Logo image of 8TRA.DE

TRATON SE (8TRA.DE) Stock Fundamental Analysis

Europe - FRA:8TRA - DE000TRAT0N7 - Common Stock

25.88 EUR
-0.7 (-2.63%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, 8TRA scores 4 out of 10 in our fundamental rating. 8TRA was compared to 103 industry peers in the Machinery industry. 8TRA has a medium profitability rating, but doesn't score so well on its financial health evaluation. 8TRA has a valuation in line with the averages, but it does not seem to be growing. 8TRA also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

8TRA had positive earnings in the past year.
8TRA had a positive operating cash flow in the past year.
Of the past 5 years 8TRA 4 years were profitable.
8TRA had a positive operating cash flow in 4 of the past 5 years.
8TRA.DE Yearly Net Income VS EBIT VS OCF VS FCF8TRA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

8TRA's Return On Assets of 3.28% is in line compared to the rest of the industry. 8TRA outperforms 53.40% of its industry peers.
The Return On Equity of 8TRA (12.58%) is better than 74.76% of its industry peers.
8TRA has a Return On Invested Capital of 6.65%. This is in the better half of the industry: 8TRA outperforms 61.16% of its industry peers.
8TRA had an Average Return On Invested Capital over the past 3 years of 7.20%. This is in line with the industry average of 8.61%.
Industry RankSector Rank
ROA 3.28%
ROE 12.58%
ROIC 6.65%
ROA(3y)3.4%
ROA(5y)2.16%
ROE(3y)12.84%
ROE(5y)8.23%
ROIC(3y)7.2%
ROIC(5y)5.08%
8TRA.DE Yearly ROA, ROE, ROIC8TRA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 4.74%, 8TRA is in the better half of the industry, outperforming 64.08% of the companies in the same industry.
In the last couple of years the Profit Margin of 8TRA has remained more or less at the same level.
8TRA's Operating Margin of 7.68% is fine compared to the rest of the industry. 8TRA outperforms 64.08% of its industry peers.
8TRA's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 20.55%, 8TRA is not doing good in the industry: 85.44% of the companies in the same industry are doing better.
8TRA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.68%
PM (TTM) 4.74%
GM 20.55%
OM growth 3Y30.59%
OM growth 5Y6.56%
PM growth 3Y58.18%
PM growth 5Y0.92%
GM growth 3Y5.57%
GM growth 5Y1.61%
8TRA.DE Yearly Profit, Operating, Gross Margins8TRA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 8TRA is creating some value.
The number of shares outstanding for 8TRA remains at a similar level compared to 1 year ago.
The number of shares outstanding for 8TRA remains at a similar level compared to 5 years ago.
The debt/assets ratio for 8TRA is higher compared to a year ago.
8TRA.DE Yearly Shares Outstanding8TRA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
8TRA.DE Yearly Total Debt VS Total Assets8TRA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

Based on the Altman-Z score of 1.16, we must say that 8TRA is in the distress zone and has some risk of bankruptcy.
8TRA has a worse Altman-Z score (1.16) than 71.84% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that 8TRA is somewhat dependend on debt financing.
8TRA has a worse Debt to Equity ratio (0.89) than 73.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.16
ROIC/WACC0.97
WACC6.85%
8TRA.DE Yearly LT Debt VS Equity VS FCF8TRA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

8TRA has a Current Ratio of 0.93. This is a bad value and indicates that 8TRA is not financially healthy enough and could expect problems in meeting its short term obligations.
8TRA has a Current ratio of 0.93. This is amonst the worse of the industry: 8TRA underperforms 89.32% of its industry peers.
A Quick Ratio of 0.61 indicates that 8TRA may have some problems paying its short term obligations.
With a Quick ratio value of 0.61, 8TRA is not doing good in the industry: 83.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.61
8TRA.DE Yearly Current Assets VS Current Liabilites8TRA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

3

3. Growth

3.1 Past

8TRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.34%.
8TRA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.03% yearly.
Looking at the last year, 8TRA shows a decrease in Revenue. The Revenue has decreased by -2.98% in the last year.
The Revenue has been growing by 12.03% on average over the past years. This is quite good.
EPS 1Y (TTM)-14.34%
EPS 3Y83.36%
EPS 5Y13.03%
EPS Q2Q%-58.12%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y15.74%
Revenue growth 5Y12.03%
Sales Q2Q%-2.49%

3.2 Future

8TRA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.95% yearly.
8TRA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.26% yearly.
EPS Next Y-31.2%
EPS Next 2Y-1.85%
EPS Next 3Y3.9%
EPS Next 5Y1.95%
Revenue Next Year-6.79%
Revenue Next 2Y-0.34%
Revenue Next 3Y1.54%
Revenue Next 5Y-0.26%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
8TRA.DE Yearly Revenue VS Estimates8TRA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
8TRA.DE Yearly EPS VS Estimates8TRA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.94, the valuation of 8TRA can be described as very cheap.
Based on the Price/Earnings ratio, 8TRA is valued cheaply inside the industry as 97.09% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 8TRA to the average of the S&P500 Index (27.40), we can say 8TRA is valued rather cheaply.
With a Price/Forward Earnings ratio of 4.79, the valuation of 8TRA can be described as very cheap.
96.12% of the companies in the same industry are more expensive than 8TRA, based on the Price/Forward Earnings ratio.
8TRA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.94.
Industry RankSector Rank
PE 5.94
Fwd PE 4.79
8TRA.DE Price Earnings VS Forward Price Earnings8TRA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 8TRA indicates a rather cheap valuation: 8TRA is cheaper than 80.58% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.31
8TRA.DE Per share data8TRA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

8TRA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.46
EPS Next 2Y-1.85%
EPS Next 3Y3.9%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.40%, 8TRA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.44, 8TRA pays a better dividend. On top of this 8TRA pays more dividend than 98.06% of the companies listed in the same industry.
8TRA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 6.4%

5.2 History

The dividend of 8TRA decreases each year by -25.42%.
Dividend Growth(5Y)-25.42%
Div Incr Years1
Div Non Decr Years4
8TRA.DE Yearly Dividends per share8TRA.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

8TRA pays out 39.01% of its income as dividend. This is a sustainable payout ratio.
DP39.01%
EPS Next 2Y-1.85%
EPS Next 3Y3.9%
8TRA.DE Yearly Income VS Free CF VS Dividend8TRA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B
8TRA.DE Dividend Payout.8TRA.DE Dividend Payout, showing the Payout Ratio.8TRA.DE Dividend Payout.PayoutRetained Earnings

TRATON SE

FRA:8TRA (10/17/2025, 7:00:00 PM)

25.88

-0.7 (-2.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-25 2025-07-25/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners5.66%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.94B
Analysts66.15
Price Target33.41 (29.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.4%
Yearly Dividend1.5
Dividend Growth(5Y)-25.42%
DP39.01%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.06%
Min EPS beat(2)-46.64%
Max EPS beat(2)-15.47%
EPS beat(4)2
Avg EPS beat(4)-9.94%
Min EPS beat(4)-46.64%
Max EPS beat(4)16.18%
EPS beat(8)3
Avg EPS beat(8)-12.32%
EPS beat(12)5
Avg EPS beat(12)-17.32%
EPS beat(16)8
Avg EPS beat(16)-4.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)-0.31%
Revenue beat(4)0
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)-0.31%
Revenue beat(8)3
Avg Revenue beat(8)-0.04%
Revenue beat(12)7
Avg Revenue beat(12)0.66%
Revenue beat(16)11
Avg Revenue beat(16)2.1%
PT rev (1m)0.24%
PT rev (3m)-2.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.54%
EPS NY rev (1m)-4.06%
EPS NY rev (3m)-23.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.62%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-3.5%
Valuation
Industry RankSector Rank
PE 5.94
Fwd PE 4.79
P/S 0.28
P/FCF N/A
P/OCF 5.2
P/B 0.75
P/tB 3.16
EV/EBITDA 5.31
EPS(TTM)4.36
EY16.85%
EPS(NY)5.4
Fwd EY20.88%
FCF(TTM)-0.86
FCFYN/A
OCF(TTM)4.98
OCFY19.24%
SpS91.98
BVpS34.64
TBVpS8.18
PEG (NY)N/A
PEG (5Y)0.46
Profitability
Industry RankSector Rank
ROA 3.28%
ROE 12.58%
ROCE 8.64%
ROIC 6.65%
ROICexc 7.23%
ROICexgc 11.16%
OM 7.68%
PM (TTM) 4.74%
GM 20.55%
FCFM N/A
ROA(3y)3.4%
ROA(5y)2.16%
ROE(3y)12.84%
ROE(5y)8.23%
ROIC(3y)7.2%
ROIC(5y)5.08%
ROICexc(3y)7.73%
ROICexc(5y)5.48%
ROICexgc(3y)12.16%
ROICexgc(5y)8.67%
ROCE(3y)9.36%
ROCE(5y)6.6%
ROICexcg growth 3Y37.39%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y42.19%
ROICexc growth 5Y7.63%
OM growth 3Y30.59%
OM growth 5Y6.56%
PM growth 3Y58.18%
PM growth 5Y0.92%
GM growth 3Y5.57%
GM growth 5Y1.61%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 2.34
Cap/Depr 95.96%
Cap/Sales 6.35%
Interest Coverage 250
Cash Conversion 37.88%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.61
Altman-Z 1.16
F-Score5
WACC6.85%
ROIC/WACC0.97
Cap/Depr(3y)77.76%
Cap/Depr(5y)69.12%
Cap/Sales(3y)5.07%
Cap/Sales(5y)5.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.34%
EPS 3Y83.36%
EPS 5Y13.03%
EPS Q2Q%-58.12%
EPS Next Y-31.2%
EPS Next 2Y-1.85%
EPS Next 3Y3.9%
EPS Next 5Y1.95%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y15.74%
Revenue growth 5Y12.03%
Sales Q2Q%-2.49%
Revenue Next Year-6.79%
Revenue Next 2Y-0.34%
Revenue Next 3Y1.54%
Revenue Next 5Y-0.26%
EBIT growth 1Y-15.12%
EBIT growth 3Y51.14%
EBIT growth 5Y19.38%
EBIT Next Year31.4%
EBIT Next 3Y20.57%
EBIT Next 5Y12.02%
FCF growth 1Y52.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.57%
OCF growth 3Y15.14%
OCF growth 5Y16.59%